Abstract

Octreotide 50-mcg/mL Injection

Author(s): Allen Loyd V Jr

Issue: Jan/Feb 2013 - Volume 17, Number 1

Page(s): 72

Download in electronic PDF format for $75
  • Octreotide 50-mcg/mL Injection Page 1

Abstract

A formulation for preparing Octreotide 50-mcg/mL Injection. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • octreotide acetate
  • formulation
  • metastatic carcinoid tumors
  • vasoactive intestinal peptide-secreting cancers
  • pancreatic cancer
  • gastrinoma
  • secretory diarrhea
  • acromegaly
  • synthetic octapeptide hormone
  • somatostatin analog

Related Categories

  • CANCER AND AIDS
  • FORMULATIONS
  • GASTROENTEROLOGY
  • PARENTERALS
  • STERILE PREPARATIONS
  • ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jan/Feb 2013
Pg. 72
Octreotide 50-mcg/mL Injection
Author(s): Allen Loyd V Jr
Jul/Aug 2000
Pg. 264-272
Providing Positive Outcomes through Compounding for Animal Cancer Patients
Author(s): Davidson Gigi S
Jul/Aug 2000
Pg. 257-260
Surviving Cancer - How the Compounding Pharmacist Can Help
Author(s): Maddox Suzan
Jan/Feb 1999
Pg. 34-35
Case Reports: Steroid Substitute Treatment for Psoriasis; Metronidazole for Odor Related to Untreated Metastatic Breast Tumor
Author(s): Mason Dave
Jan/Feb 2013
Pg. 64
Desmopressin 4-mcg/mL Injection
Author(s): Allen Loyd V Jr
Jan/Feb 2021
Pg. 18-23
Reversing Erectile Dysfunction and Urinary Incontinence After Prostatectomy or Radiotherapy: The Stanley Prostate-Cancer Treatment Protocol
Author(s): McKettrick Greg, Yoch Doug
Jul/Aug 2002
Pg. 250-254
The Hormonal Link to Breast Cancer: The Estrogen Matrix
Author(s): Zava David T
May/Jun 2005
Pg. 195-198
Compounding Antiangiogenic Cancer Therapy for Animals
Author(s): Davidson Gigi S
Sep/Oct 2016
Pg. 359-364
Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1
Author(s): Deleruyelle Laura J
Nov/Dec 2016
Pg. 447-454
Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2
Author(s): Deleruyelle Laura J
Sep/Oct 2017
Pg. 411
Fentanyl Citrate 50-mcg/mL Injection
Author(s): Allen Loyd V Jr
Jan/Feb 2001
Pg. 52-54
Using Serum Hormone Analysis to Develop Hormone Replacement Therapy Regimens - Part 2
Author(s): Ford Gina, Garcia Lea
Jul/Aug 2012
Pg. 340
Sufentanil Citrate 50-mcg/mL Injection
Author(s): Allen Loyd V Jr
Mar/Apr 2010
Pg. 100-104
Hormonal Influences in Prostate Cancer: An Update of a Complex Subject
Author(s): Biundo Bruce
Jan/Feb 2009
Pg. 42-49
Compounding for Cancer in Companion Animals
Author(s): Mixon William, Northrup Nicole, Vail Jane
Jan/Feb 2008
Pg. 62
Calculations: Compounding for Cancer Patients
Author(s): Stockton Shelly J
Jan/Feb 2008
Pg. 16-27
Cancer-Related Terminology: Glossaries for Compounding Pharmacists and Their Clients
Author(s): Williams LaVonn A
May/Jun 2013
Pg. 262-263
PostScription: The Pharmacist's Role in the Treatment of Cancer: A Personal Plea and Testimonial
Author(s): Williams LaVonn A
Mar/Apr 2014
Pg. 148
Secretin 4 mcg/mL Injection
Author(s): Allen Loyd V Jr
Jan/Feb 1998
Pg. 21-23
Estrogen and Breast Cancer: Is There a Link?
Author(s): Gever Marcy Portnoff